Professional Advisory Services’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-72,773
Closed -$11.3M 69
2019
Q4
$11.3M Sell
72,773
-1,984
-3% -$286K 2.01% 28
2019
Q3
$10.1M Sell
74,757
-34,928
-32% -$4.58M 1.92% 29
2019
Q2
$13.4M Sell
109,685
-12,969
-11% -$1.44M 2.6% 22
2019
Q1
$12.8M Buy
122,654
+41,573
+51% +$4.29M 2.56% 24
2018
Q4
$9.23M Sell
81,081
-30,316
-27% -$3.25M 2.06% 28
2018
Q3
$12.8M Sell
111,397
-2,876
-3% -$315K 2.53% 26
2018
Q2
$11.8M Sell
114,273
-6,523
-5% -$660K 2.44% 27
2018
Q1
$11.9M Sell
120,796
-17,556
-13% -$1.66M 2.57% 25
2017
Q4
$11.7M Sell
138,352
-38,741
-22% -$3.2M 2.47% 27
2017
Q3
$13.6M Sell
177,093
-3,705
-2% -$283K 2.9% 19
2017
Q2
$14.1M Sell
180,798
-12,248
-6% -$876K 3.05% 17
2017
Q1
$13.9M Sell
193,046
-11,229
-5% -$776K 3.08% 15
2016
Q4
$12.7M Buy
204,275
+9,980
+5% +$611K 2.95% 20
2016
Q3
$12.6M Sell
194,295
-18,225
-9% -$1.21M 2.87% 22
2016
Q2
$13.4M Buy
212,520
+35,174
+20% +$2.07M 3.07% 15
2016
Q1
$10.3M Sell
177,346
-1,028
-0.6% -$58.2K 2.42% 25
2015
Q4
$9.58M Buy
178,374
+29,867
+20% +$1.68M 2.28% 24
2015
Q3
$7.57M Buy
+148,507
New +$7.99M 1.9% 27

Other funds holding RMD

Professional Advisory Services's RMD Position: Q1 2020 in Review

Professional Advisory Services sold out of ResMed (RMD) in Q1 2020, closing a stake of 72,773 shares — an estimated $11.3M sold.

Professional Advisory Services first reported a position in RMD in Q3 2015 and held it in 18 quarters. The position peaked at $14.1M in Q2 2017. 584 funds tracked by Wall St. Rank hold RMD as of Q1 2020.

  • Professional Advisory Services reported no remaining ResMed position as of Q1 2020 after selling out during the quarter.
  • Professional Advisory Services sold 72,773 ResMed shares in Q1 2020, an estimated $11.3M.
  • Professional Advisory Services first reported a position in ResMed in Q3 2015 and held it in 18 quarters.
  • Professional Advisory Services's ResMed position peaked at $14.1M in Q2 2017.
  • 584 funds tracked by Wall St. Rank held ResMed as of Q1 2020.

Based on Professional Advisory Services's 13F filing for Q1 2020, filed 23 Apr 2020.